PPCB:US
$6.64
18.996%

Propanc Biopharma Inc
News & Events

Last updated: Jun 8, 2025, 8:12 PM ET

  1. Propanc Biopharma's Peer Reviewed Articles for Proenzymes Cancer Treatment Generates "Unprecedented" Interest

    Business Wire AUG 21, 2024 9:00 AM EDT
    Two Publications Reach 10 Citations & 4,500 Reads, Respectively Propanc Bioph...
    READ ARTICLE
  2. Propanc Biopharma Receives Notice of Allowance for "Proenzyme Composition" Patent in North America

    Business Wire AUG 14, 2024 9:00 AM EDT
    Patent Broadly Captures Both High Dose & High Ratio Claims for Future Clinical Doses of PRP A...
    READ ARTICLE
  3. Propanc Biopharma's CSO Predicts PRP Could Solve Problem That Impacts Response Rate of Immune Checkpoint Inhibitors Treating Solid Tumors

    Business Wire JUL 17, 2024 9:00 AM EDT
    British Journal of Cancer Concludes Tumor cell-intrinsic PD-L1 function promotes EMT ...
    READ ARTICLE
  4. Propanc Biopharma Receives Certificate of Grant for "Proenzymes Composition" Patent from Japanese Patent Office

    Business Wire JUN 25, 2024 9:00 AM EDT
    Certificate of Grant Received for “Cancer Treatment” Patent from IP Corporation of ...
    READ ARTICLE
  5. Sidoti's November Micro-Cap Virtual Conference

    ACCESS Newswire NOV 8, 2022 3:40 PM EST
    Presentation Times and Weblinks Released for Over 35 Presenting Companies Wednesday an...
    READ ARTICLE
  6. SeeThruEquity Issues Update on Propanc Biopharma, Inc.

    ACCESS Newswire JUN 19, 2017 10:00 AM EDT
    NEW YORK, NY / ACCESSWIRE / June 19, 2017 / SeeThruEquity, a leading independent equity rese...
    READ ARTICLE

Upcoming Events

Get notified of Propanc Biopharma Inc’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available